[{"NetIncomeLoss_2_Q2_USD":-806000.0,"Depreciation_2_Q2_USD":193000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2256000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":58172000.0,"PreferredStockValueOutstanding_0_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedRoyaltiesCurrent_0_Q2_USD":164000.0,"Depreciation_1_Q2_USD":102000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":2.56,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":97097.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":263000.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":43924000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":179759000.0,"RepaymentsOfSecuredDebt_2_Q2_USD":833000.0,"OtherAssetsNoncurrent_0_Q2_USD":199000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":69081000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":26.44,"Assets_0_Q2_USD":201546000.0,"CommonStockSharesIssued_0_Q2_shares":19373869.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":330000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":401000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":2870000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2855000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":69081000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":2146000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":10392000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":21470000.0,"AccountsReceivableNetNoncurrent_0_Q2_USD":652000.0,"LongTermDebtCurrent_0_Q2_USD":10000000.0,"AssetsCurrent_0_Q2_USD":195671000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":290120.0,"CostOfGoodsAndServicesSold_2_Q2_USD":4537000.0,"AccruedBonusesCurrentAndNoncurrent_0_Q2_USD":3060000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":444000.0,"AccountsReceivableNetCurrent_0_Q2_USD":12528000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":0.0,"ProceedsFromStockPlans_2_Q2_USD":823000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":17544000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":17458000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"RepaymentsOfLongTermLinesOfCredit_2_Q2_USD":0.0,"EarningsPerShareBasic_2_Q2_USD":-0.05,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":16.15,"ResearchAndDevelopmentExpense_1_Q2_USD":2704000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5617000.0,"OtherOperatingIncome_1_Q2_USD":1882000.0,"OtherOperatingIncome_2_Q2_USD":1882000.0,"EarningsPerShareBasic_1_Q2_USD":-0.08,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q2_USD":0.0,"InterestPayableCurrent_0_Q2_USD":172000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":438000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-1376000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-806000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-1376000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-806000.0,"IncreaseDecreaseInInventories_2_Q2_USD":430000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":0.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q2_USD":0.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_2_Q2_USD":0.0,"StockIssuedDuringPeriodSharesNewIssues_0_Q2_shares":2000000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":1653000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_Q2_USD":3230000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":69920000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1127000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":24850.0,"ShareBasedCompensation_2_Q2_USD":3230000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":2.39,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":69530000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1717000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":179759000.0,"InterestExpense_1_Q2_USD":769000.0,"InterestExpense_2_Q2_USD":1533000.0,"AccountsPayableCurrent_0_Q2_USD":2495000.0,"LiabilitiesCurrent_0_Q2_USD":28242000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":17544000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":13250000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2_Q2_shares":856545.0,"ProceedsFromShortTermDebt_2_Q2_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1396000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":2291000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":1048000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":17458000.0,"LongTermDebtNoncurrent_0_Q2_USD":14741000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2746000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":79000.0,"NetIncomeLoss_1_Q2_USD":-1376000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5024000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":22076000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":194000.0,"ProceedsFromIssuanceOfSecuredDebt_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"IncomeLossAttributableToParent_1_Q2_USD":-1376000.0,"IncomeLossAttributableToParent_2_Q2_USD":-806000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":603000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":202975.0,"AdditionalPaidInCapital_0_Q2_USD":210621000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":62000.0,"GrossProfit_1_Q2_USD":10569000.0,"GrossProfit_2_Q2_USD":25596000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.08,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":8350000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.05,"OtherSundryLiabilitiesCurrent_0_Q2_USD":10000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":8350000.0,"InvestmentIncomeInterest_1_Q2_USD":38000.0,"InvestmentIncomeInterest_2_Q2_USD":336000.0,"InventoryNet_0_Q2_USD":1667000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":1454402.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":33.04,"OperatingIncomeLoss_1_Q2_USD":-645000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":12715000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":30133000.0,"CommonStockValueOutstanding_0_Q2_USD":19000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-234000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingIncomeLoss_2_Q2_USD":391000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.97,"LiabilitiesAndStockholdersEquity_0_Q2_USD":201546000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4651000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-2337000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":80914000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-53018000.0,"TemporaryEquityDividendsAdjustment_1_Q2_USD":0.0,"TemporaryEquityDividendsAdjustment_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":628392.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2700261.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":452000.0,"DeferredRentCreditNoncurrent_0_Q2_USD":941000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2256000.0,"StockholdersEquity_0_Q2_USD":157622000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6420000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1653000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3230000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"CommonStockSharesOutstanding_0_Q2_shares":19373869.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1883000.0,"Ticker":"CSTL","CIK":"1447362","name":"CASTLE BIOSCIENCES INC","OfficialName":"Castle Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"617985841.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]